- France reported a Shamonda virus infection in a severely immunocompromised patient who died in early October.
- WHO and European health authorities are examining how the patient became infected and whether the virus contributed to the death.
- French authorities say no risk to the general population has been identified based on current knowledge.
New Delhi: France has reported the first documented human infection with the Shamonda virus, a pathogen previously associated with animals, particularly cattle. The case involves a severely immunocompromised patient who died in early October, prompting investigations by French authorities and the World Health Organization (WHO).
The European Centre for Disease Prevention and Control (ECDC) is also monitoring the situation. Authorities have said that no public health risk to the general population has been identified based on the information currently available.
The case has drawn attention because the virus was previously considered unable to infect humans. Investigators are now examining how the patient acquired the infection and whether it contributed to the death.
What Is the Shamonda Virus?
Shamonda virus belongs to the Orthobunyavirus group and was first identified in Nigeria in the 1960s. It has historically been detected in animals in parts of Africa and Japan.
The virus is primarily associated with livestock, especially cattle. It can spread between animals through the bites of infected Culicoides midges, small flying insects.
The virus was detected in European farm animals for the first time in 2026. France and several other European countries have reported infections in livestock, leading health and animal-disease authorities to strengthen surveillance.
Until the French case was documented, no human infection with the virus had been reported.
How Did the Patient Become Infected?
The exact route of infection has not yet been conclusively established.
French authorities consider transmission through the bite of an infected midge in eastern France a leading possibility. The virus had circulated among animals in the region during the spring and summer of 2026.
The patient was receiving treatment for a serious underlying illness that had severely weakened the immune system. Authorities are examining clinical, biological and epidemiological evidence to understand the infection.
The investigations also aim to establish the relationship between the virus and the patient’s death. The patient died in early October, but the full circumstances remain under investigation.
WHO and European Health Authorities Monitor the Case
The WHO is working with French authorities to investigate the source of the infection and determine possible transmission routes.
The ECDC has also confirmed that it is monitoring the situation and coordinating with French authorities and European partners to assess potential public health implications.
These investigations are important because the case represents a previously undocumented human infection. Further evidence is needed to establish how the virus behaves in humans and whether other infections have occurred.
Authorities are continuing to examine the case rather than drawing conclusions about the possibility of wider transmission.
Is the Shamonda Virus a Risk to the General Public?
French authorities have stated that no health risk to the general population has been identified at this time.
The fact that one human infection has been documented does not, by itself, establish that the virus spreads readily between people. Its transmission mechanisms in humans remain under investigation.
The patient’s severely weakened immune system is also an important factor when interpreting the case. More evidence is needed to determine whether the infection could affect people with different immune-system conditions.
There is currently insufficient evidence to make definitive conclusions about the severity of Shamonda virus infection in humans.
What Happens Next?
Health experts will continue examining how the infection occurred, the possible role of insect transmission and whether the virus contributed to the patient’s death.
The ECDC is working with European partners to strengthen testing capacity and support the identification of any additional cases, should they emerge.
For now, authorities have not identified a wider public health risk. The situation remains under investigation, and further findings will help clarify the significance of this first documented human infection.
You May Like
Amazon Online Shopping
